GSK
Lessons from the Phase III ZEST trial could inform ongoing and future trials as they seek to use ctDNA to prove efficacy of novel adjuvant treatments.
UK Parkinson’s Single-Cell Research Project Kicks off With £4M From Gatsby Charitable Foundation
The three-year public-private research partnership has also garnered financial support from pharmaceutical companies GSK, Novartis, Roche, and UCB.
Project Africa GRADIENT aims to gather and analyze pharmacogenetic data specific to African populations with funding from Novartis and GlaxoSmithKline.
Elegen Raises $35M in Series B Financing Round
In a statement, Elegen said it would use the funding to extend its production for clinical development of genetic medicines.
GSK, Elegen Ink Collaboration and Licensing Agreement for Synthetic DNA
GSK will provide Elegen with up to $35 million in near-term support and has made commitments to purchase synthetic DNA for use in developing genetic medicines.
Nov 30, 2023
Feb 21, 2023
Oct 25, 2021
Oct 7, 2020